Number of the records: 1
Binding of tissue-type plasminogen activator to human melanoma cells
Title Binding of tissue-type plasminogen activator to human melanoma cells Author Bizik Jozef 1956- SAVEXONK - Ústav experimentálnej onkológie SAV ORCID Co-authors Grófová M. Vaheri A. Co-authors Stephens Ross W. Source document Journal of Cellular Biochemistry. Vol. 51, no. 3 (1993), p. 326-335 Language eng - English Document kind rozpis článkov z periodík (rbx) Citations DIAZ, VM - HURTADO, M - THOMSON, TM - REVENTOS, J - PACIUCCI, R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. In GUT. ISSN 0017-5749, 2004, vol. 53, no. 7, pp. 993. STACK, MS - GATELY, S - BAFETTI, LM - ENGHILD, JJ - SOFF, GA. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. In BIOCHEMICAL JOURNAL. ISSN 0264-6021, 1999, vol. 340, no., pp. 77. AWAD, EM. In vitro decreases of the fibrinolytic potential of cultured human fibrosarcoma cell line, HT1080, by Nigella sativa oil. In PHYTOMEDICINE. ISSN 0944-7113, 2005, vol. 12, no. 1-2, pp. 100. CHANG, Y - NILSEN, SL - CASTELLINO, FJ. Functional and structural consequences of aromatic residue substitutions within the kringle-2 domain of tissue-type plasminogen activator. In JOURNAL OF PEPTIDE RESEARCH. ISSN 1397-002X, 1999, vol. 53, no. 6, pp. 656. TRANTHANG, C - VOUILLAMOZ, D - KRUITHOF, EKO - SORDAT, B. HUMAN CO115 COLON-CARCINOMA CELLS POTENTIATE THE DEGRADATION OF LAMININ MEDIATED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR. In JOURNAL OF CELLULAR PHYSIOLOGY. ISSN 0021-9541, 1994, vol. 161, no. 2, pp. 285. MIGNATTI, P - RIFKIN, DB. Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology. In ADVANCES IN CANCER RESEARCH, VOL 78. ISSN 0065-230X, 2000, vol. 78, no., pp. 103. GONZALEZ-GRONOW, Mario - RAY, Rupa - WANG, Fang - PIZZO, Salvatore V. The Voltage-dependent Anion Channel (VDAC) Binds Tissue-type Plasminogen Activator and Promotes Activation of Plasminogen on the Cell Surface. In JOURNAL OF BIOLOGICAL CHEMISTRY. ISSN 0021-9258, 2013, vol. 288, no. 1, pp. 498. CHANG, Y - ZAJICEK, J - CASTELLINO, FJ. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties. In BIOCHEMISTRY. ISSN 0006-2960, 1997, vol. 36, no. 25, pp. 7652. DEVRIES, TJ - VANMUIJEN, GNP - RUITER, DJ. The plasminogen activation system in melanoma cell lines and in melanocytic lesions. In MELANOMA RESEARCH. ISSN 0960-8931, 1996, vol. 6, no. 2, pp. 79. MUELLER, BM. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis. In ATTEMPTS TO UNDERSTAND METASTASIS FORMATION I. ISSN 0070-217X, 1996, vol. 213, no., pp. 65. SORDAT, BCM - TRANTHANG, C. LAMININ DEGRADATION BY HUMAN COLON-CARCINOMA CELLS A ROLE FOR URINARY AND TISSUE-PLASMINOGEN ACTIVATORS. In INVASION & METASTASIS. ISSN 0251-1789, 1994, vol. 14, no. 1-6, pp. 223. BYDOUN, Moamen - WAISMAN, David M. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity. In FUTURE ONCOLOGY. ISSN 1479-6694, 2014, vol. 10, no. 15, pp. 2469. NOORMAN, F - BRAAT, EAM - RIJKEN, DC. DEGRADATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY HUMAN MONOCYTE-DERIVED MACROPHAGES IS MEDIATED BY THE MANNOSE RECEPTOR AND BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN. In BLOOD. ISSN 0006-4971, 1995, vol. 86, no. 9, pp. 3421. HACHIYA, T - NAKANO, H - WAKE, N - SUEISHI, R. IN-VITRO INVASIVENESS OF HUMAN BREAST-CANCER CELLS THROUGH PLASMINOGEN-ACTIVATOR ACTIVITY INDEPENDENTLY REGULATED BY HORMONES AND TRANSFORMING GROWTH-FACTOR-BETA-1. In CANCER JOURNAL. ISSN 0765-7846, 1995, vol. 8, no. 1, pp. 13. GHOSH, S - ELLERBROEK, SM - WU, Y - STACK, MS. Tumor cell-mediated proteolysis: regulatory mechanisms and functional consequences. In FIBRINOLYSIS & PROTEOLYSIS. ISSN 0268-9499, 2000, vol. 14, no. 2-3, pp. 87. LELOUP, G - LEMOINE, P - CARMELIET, P - VAES, G. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor. In JOURNAL OF BONE AND MINERAL RESEARCH. ISSN 0884-0431, 1996, vol. 11, no. 8, pp. 1146. KRAMER, MD - REINARTZ, J - BRUNNER, G - SCHIRRMACHER, V. PLASMIN IN PERICELLULAR PROTEOLYSIS AND CELLULAR INVASION. In INVASION & METASTASIS. ISSN 0251-1789, 1994, vol. 14, no. 1-6, pp. 210. FERRIER, CM - VAN MUIJEN, GNP - RUITER, DJ. Proteases in cutaneous melanoma. In ANNALS OF MEDICINE. ISSN 0785-3890, 1998, vol. 30, no. 5, pp. 431. GONZALEZ-GRONOW, Mario - FIEDLER, Jenny L. - FARIAS GOMEZ, Cristian - WANG, Fang - RAY, Rupa - FERRELL, Paul D. - PIZZO, Salvatore. V. Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent L-lysine-containing domains. In BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. ISSN 0006-291X, 2017, vol. 490, no. 3, pp. 855-860. MAEDA, K. Mechanism of Action of Topical Tranexamic Acid in the Treatment of Melasma and Sun-Induced Skin Hyperpigmentation. In COSMETICS. OCT 2022, vol. 9, no. 5. Dostupné na: https://doi.org/10.3390/cosmetics9050108. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 1993 Registered in WOS 
unrecognised
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 1993
Number of the records: 1